Nearmap Ltd buy krebskrebs
Start price
22.02.21
/
50%
€1.69
Target price
22.02.22
€2.50
Performance (%)
-54.14%
End price
23.02.22
€0.78
Summary
This prediction ended on 23.02.22 with a price of €0.78. The BUY prediction by krebskrebs for Nearmap Ltd performed very badly with a performance of -54.14%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Nearmap Ltd | - | - | - | - |
iShares Core DAX® | 2.749% | 4.620% | 17.121% | 21.210% |
iShares Nasdaq 100 | 0.470% | -0.331% | 37.776% | 57.865% |
iShares Nikkei 225® | -2.930% | -5.556% | 12.185% | 8.407% |
iShares S&P 500 | 0.679% | 0.631% | 28.996% | 48.197% |
Comments by krebskrebs for this prediction
In the thread Nearmap Ltd diskutieren
Buy mit Kursziel 2,5
In the thread Trading Nearmap Ltd
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten